EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Antibody-Based Antigen Delivery to Dendritic Cells as a Vaccination Strategy Against Ebola Virus Disease

Catherine Olal iD, Bianca S Bodmer iD, Monika Rottstegge, Beatriz Escudero-Pérez iD, Julia R Port iD, András Bencsik iD, Emily V Nelson, Michelle Heung, Stephanie Wurr iD, Olivia Blake, Elisa Adam, Lisa Oestereich und 8 weitere

The Journal of Infectious Diseases · 15.04.2025 · 231 (4) · e615-e625

DOI: 10.1093/infdis/jiae613 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, online erschienen am 14.01.2025. Verfasst von Catherine Olal und 19 weiteren Autor:innen. Beteiligte Einrichtung: Bernhard Nocht Institute for Tropical Medicine, Hamburg. Hauptthemen laut MEDLINE: Dendritic Cells, Hemorrhagic Fever, Ebola, Ebolavirus, Ebola Vaccines. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: German Center for Infection Research, European Federation of Pharmaceutical Industries and Associations, Innovative Medicines Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dendritic cells connect innate and adaptive immune responses. This is a particularly important immune checkpoint in the case of emerging infections against which most of the population does not have preexisting antibody immunity. In this study, we sought to test whether antibody-based delivery of Ebola virus (EBOV) antigens to dendritic cells could be used as a vaccination strategy against Ebola virus disease. Our approach was to use antibodies targeting the endocytic receptor DEC-205 present in murine and human dendritic cells, to deliver the EBOV nucleoprotein or the model antigen ovalbumin (OVA). Our findings indicate that DEC-205 targeting stimulated antigen-specific T-cell responses in mice, which resulted in protection from EBOV or recombinant EBOV-OVA challenge. An added value of this strategy was the generation of resident memory T cells. We propose that dendritic cell targeting could be used to improve T-cell responses against filoviruses, a strategy that may complement current vaccination strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsHemorrhagic Fever, EbolaEbolavirusEbola VaccinesAntibodies, ViralAntigens, ViralAnimalsMiceHumansOvalbuminMice, Inbred C57BLVaccinationLectins, C-TypeReceptors, Cell SurfaceFemaleAntigens, CDMinor Histocompatibility Antigens

Stichwörter der Autor:innen

DEC-205Ebola virusT cellsdendritic cellsvaccination

Substanzen

Ebola VaccinesAntibodies, ViralOvalbuminDEC-205 receptorAntigens, ViralLectins, C-TypeReceptors, Cell SurfaceAntigens, CDMinor Histocompatibility Antigens

Autor:innen und Institutionen

  • Bernhard Nocht Institute for Tropical Medicine, Hamburg.
  • German Center for Infection Research, partner site Hamburg-Borstel-Lübeck-Riems, Hamburg.
  • Institute of Molecular Virology and Cell Biology, Friedrich Loeffler Institut, Greifswald-Insel Riems.
  • Institute for Infection Research and Vaccine Development, University Medical Centre Hamburg-Eppendorf, Hamburg.
  • Laboratory of Transmission Immunology, Hemholtz Centre for Infection Research, Braunschweig, Germany.
  • Zendal Health S.A., Torneiros, Galicia, Spain.

ORCID-Profile: Catherine Olal, Bianca S Bodmer, Beatriz Escudero-Pérez, Julia R Port, András Bencsik, Stephanie Wurr, Fabienne Anjuère, Juliana Idoyaga, Thomas Hoenen, César Muñoz-Fontela

Förderung

  • German Center for Infection Research
  • European Federation of Pharmaceutical Industries and Associations
  • Innovative Medicines Initiative
  • FLI
  • VISION consortium
  • Innovative Medicines Initiative 2 Joint Undertaking

Zitieren

APA

Olal, C., Bodmer, B. S., Rottstegge, M., Escudero-Pérez, B., Port, J. R., Bencsik, A., Nelson, E. V., Heung, M., Wurr, S., Blake, O., Adam, E., Oestereich, L., Baz-Martínez, M., Müller-Guhl, J., Gallais, Y., Anjuère, F., Malliere, B., Idoyaga, J., Hoenen, T., & Muñoz-Fontela, C. (2025). Antibody-Based Antigen Delivery to Dendritic Cells as a Vaccination Strategy Against Ebola Virus Disease. The Journal of Infectious Diseases, 231(4), e615-e625. https://doi.org/10.1093/infdis/jiae613

Vancouver

Olal C, Bodmer BS, Rottstegge M, Escudero-Pérez B, Port JR, Bencsik A, et al. Antibody-Based Antigen Delivery to Dendritic Cells as a Vaccination Strategy Against Ebola Virus Disease. The Journal of Infectious Diseases. 2025;231(4):e615-e625. doi:10.1093/infdis/jiae613

BibTeX
@article{Olal2025,
  author = {Olal, Catherine and Bodmer, Bianca S and Rottstegge, Monika and Escudero-Pérez, Beatriz and Port, Julia R and Bencsik, András and Nelson, Emily V and Heung, Michelle and Wurr, Stephanie and Blake, Olivia and Adam, Elisa and Oestereich, Lisa and Baz-Martínez, Maite and Müller-Guhl, Jürgen and Gallais, Yann and Anjuère, Fabienne and Malliere, Bernard and Idoyaga, Juliana and Hoenen, Thomas and Muñoz-Fontela, César},
  title = {Antibody-Based Antigen Delivery to Dendritic Cells as a Vaccination Strategy Against Ebola Virus Disease},
  journal = {The Journal of Infectious Diseases},
  year = {2025},
  volume = {231},
  number = {4},
  pages = {e615--e625},
  doi = {10.1093/infdis/jiae613}
}
Kostenlos starten →